Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of Control-IQ Technology on Quality of Life and Glycemic Control in Children and Youth With Type 1 Diabetes in a Canadian Context

NCT04838561 is registered in ClinicalTrials.gov with Children's Hospital of Eastern Ontario as lead sponsor.

NCT NCT04838561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04838561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of Control-IQ Technology on Quality of Life and Glycemic Control in Children and Youth With Type 1 Diabetes in a Canadian Context
Lead sponsor
Children's Hospital of Eastern Ontario
Phase
Observational
Overall status
Completed
Start date
March 15, 2021
Completion date
October 26, 2021
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes